In a recent court decision, the Federal Circuit has reignited the debate surrounding the connection between intellectual property licensing and procurement deals. A software developer’s allegations of data misappropriation by the U.S. Food and Drug Agency, under a government contract, have been deemed valid for a lawsuit under the Contract Disputes Act.
The case in question, which was brought to light by the plaintiff, accuses the U.S. Food and Drug Agency of wrongfully appropriating its data. At the heart of the dispute is the question of whether an intellectual property license can form part of a procurement deal, an issue previously unchartered in law.
After initial dismissal of the case, it found a fresh lease of life as the Federal Circuit ruled in favor of the software developer. The court held that the plaintiff had convincingly asserted its part in a government contract, thus enabling claims under the Contract Disputes Act.
The ruling does not only breathe new life into the software developer’s claims but also pioneers a fresh perspective on intellectual property licenses and their possible inclusion in procurement deals. While the final verdict in the case remains anticipated, the path towards the discourse of such agreements in a judicial setting has just broadened.
More detailed information regarding the case and its proceedings can be found at Law360.